Lv5
850 积分 2024-01-11 加入
Barrier to autointegration factor 1, procollagen‐lysine, 2‐oxoglutarate 5‐dioxygenase 3, and splicing factor 3b subunit 4 as early‐stage cancer decision markers and drivers of hepatocellular carcinoma
1天前
待确认
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease
3天前
已完结
Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems
5天前
已完结
Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy
5天前
已完结
The Dual‐Target Nanoparticles with ROS Sensitivity Inhibit the Hedgehog Signaling Pathway and Decrease Oxidative Stress in Activated Hepatic Stellate Cells to Alleviate Liver Fibrosis
5天前
已完结
In Situ Assembly of Fluorogenic RNA for Screening Natural Anti‐Liver Fibrosis Products via Dynamic Visualization of COL1A1 mRNA
21天前
已完结
Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy
21天前
已完结
Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas
21天前
已完结
Remodeling liver microenvironment by L-arginine loaded hollow polydopamine nanoparticles for liver cirrhosis treatment
28天前
已完结
Prevention of acute thrombosis with vascular endothelium antioxidative nanoscavenger
28天前
已完结
皖公网安备34019202002308
